Several clinical trials are underway to evaluate the efficacy of MRP1 inhibitors and other approaches in overcoming drug resistance. These trials aim to improve the outcomes of existing chemotherapeutic regimens by targeting MRP1. The results from these studies are eagerly awaited and have the potential to significantly impact cancer treatment protocols.
